Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy

Signal Transduct Target Ther. 2024 Apr 30;9(1):117. doi: 10.1038/s41392-024-01835-y.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Cell- and Tissue-Based Therapy
  • Humans
  • Mutation*
  • T-Lymphocytes* / immunology